Cargando…
Fabry disease – current data and therapeutic approaches
Fabry disease represents an X-linked inherited disorder resulting in the accumulation of globotriaosylceramide (Gb3). This review explains the clinical manifestations and the possible therapies for this condition. Fabry disease is considered the second most frequent lysosomal storage disease. More t...
Autores principales: | Dinu, Ilie-Robert, Firu, Ştefan-George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597377/ https://www.ncbi.nlm.nih.gov/pubmed/34609404 http://dx.doi.org/10.47162/RJME.62.1.01 |
Ejemplares similares
-
Current and experimental therapeutics for Fabry disease
por: Castelli, Vanessa, et al.
Publicado: (2021) -
Current and Investigational Therapeutics for Fabry Disease
por: Felis, Andrew, et al.
Publicado: (2019) -
Fabry Disease: The Current Treatment Landscape
por: Lenders, Malte, et al.
Publicado: (2021) -
Multidisciplinary Management of Fabry Disease: Current Perspectives
por: Paim-Marques, Luciana, et al.
Publicado: (2022) -
Neuroimaging in Fabry disease: current knowledge and future directions
por: Cocozza, Sirio, et al.
Publicado: (2018)